PSMA-PET/CT与mpMRI在前列腺癌大体肿瘤体积勾画中的逐层病理对照研究
本研究以前列腺全切标本全mount病理为参考标准,对17例原发性前列腺癌患者行[68Ga-]PSMA-11 PET/CT与mpMRI,逐层分区比较两种影像勾画大体肿瘤体积(GTV)的准确性。结果显示PSMA-PET敏感度86%、特异度87%,mpMRI为58%和94%;mpMRI所勾画肿瘤体积显著小于病理与PET。提示PSMA-PET与病理一致性更高,可作为局灶放疗GTV勾画的补充。
要点
- PSMA-PET敏感度86%、特异度87%,mpMRI为58%和94%。
- mpMRI勾画GTV中位4.5 ml,显著小于病理10.4 ml与PET 10.8 ml。
- PSMA-PET在133个分区正确识别肿瘤而mpMRI未发现。
核心结论
- PSMA-PET/CT与病理的一致性高于mpMRI,敏感度更高,可作为局灶治疗GTV勾画的补充。
研究设计与样本
- 前瞻性纳入17例原发性前列腺癌患者,根治性前列腺切除术前均行[68Ga-]PSMA-11 PET/CT与mpMRI检查。
- 影像与全mount病理进行配准,由两组专家分别勾画mpMRI与PET的GTV,按病灶水平及逐层四分区验证,共分析772个分区,其中414个为肿瘤真阳性(53.6%)。
主要发现
- GTV-histo中位肿瘤体积10.4 ml,PSMA-PET为10.8 ml,mpMRI为4.5 ml。
- mpMRI中位肿瘤体积显著小于GTV-PET与GTV-histo(p < 0.05)。
- PSMA-PET敏感度86%、特异度87%;mpMRI敏感度58%、特异度94%;两者GTV并集敏感度91%、特异度84%。
- 在133个分区中PSMA-PET/CT正确识别肿瘤而mpMRI未发现,mpMRI仅独家识别19个真阳性分区。
临床怎么用
- 在原发性前列腺癌局灶放疗GTV勾画中,PSMA-PET/CT可补充mpMRI,以减少肿瘤漏勾并改善体积覆盖。
- mpMRI勾画GTV存在显著低估肿瘤体积的风险,需结合PSMA-PET信息综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Focal therapies are a promising approach to treat prostate cancer (PCa) more precisely instead of conventional whole gland treatment. Nowadays, multiparametric MRI (mpMRI) is routinely used for gross tumor volume (GTV) delineation. The aim of our study was to compare PSMA-PET/CT and mpMRI for the delineation of intraprostatic tumor burden by using whole mount histopathology as a reference standard. MATERIAL AND METHODS: 17 prospectively enrolled patients with primary PCa underwent [68Ga-]PSMA-11 PET/CT and mpMRI before radical prostatectomy. PSMA-PET/CT, mpMRI and histopathology of the resected specimens were co-registered. Two teams of experts generated GTV contours for mpMRI and PET, respectively. The imaging was validated on a lesion level and slice by slice in quadrants based on the distribution of PCa in histopathology. Overall, 772 quadrants were analyzed with 414 being true positive for tumor (53.6%). RESULTS: Median tumor volumes were 10.4 ml for GTV-histo, 10.8 ml for PSMA-PET and 4.5 ml for mpMRI. Median tumor volume in mpMRI was significant (p < 0.05) smaller than GTV-PET and GTV-histo, respectively. The sensitivity and specificity were 86% and 87% for PSMA-PET, 58% and 94% for mpMRI and 91% and 84% for their GTV-union. In 133 quadrants PSMA-PET/CT correctly identified tumor where mpMRI found none. MpMRI identified 19 true positive quadrants exclusively. CONCLUSION: Our investigation demonstrates an increased consensus of PSMA-PET with histopathology compared to mpMRI for intraprostatic GTV delineation, especially with a higher sensitivity. Additionally mpMRI contours underestimate tumor volume significantly. Thus PSMA-PET may be a complementary augmentation for GTV delineation in focal therapies.
引用
- Bettermann AS, Zamboglou C, Kiefer S, et al. [68Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - Implications for focal radiotherapy planning in primary prostate cancer. Radiother Oncol. 2019. PMID: 31431366. doi:10.1016/j.radonc.2019.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。